


Primary insider and Chief Operating Officer Tor Erik Andersen subscribed,
through his fully owned company Torsen Holding AS, for 750,000 new shares in the
Private Placement on Friday, 22 April 2016.

After the transaction, Mr. Andersen holds 1,907,142 shares, representing 1.56
percent of Hofseth BioCare ASA, directly and through Torsen Holding AS.

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.


[HUG#2006260] 
    